Schizophrenia

F5_SCHZPHR

schizophrenia: A major psychotic disorder characterized by abnormalities in the perception or expression of reality. It affects the cognitive and psychomotor functions. Common clinical signs and symptoms include delusions, hallucinations, disorganized thinking, and retreat from reality.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F20 Hospital discharge: ICD-9 — 295 Hospital discharge: ICD-8 — 295 Hospital discharge: excluded ICD-9 — 2954\|2957 Hospital discharge: excluded ICD-8 — 2957 Cause of death: ICD-10 — F20 Cause of death: ICD-9 — 295 Cause of death: ICD-8 — 295 Cause of death: excluded ICD-9 — 2954\|2957 Cause of death: excluded ICD-8 — 2957 2 out of 7 registries used, show all original rules.	7501
4. Check minimum number of events None	7501
5. Include endpoints None	7501
6. Filter based on genotype QC (FinnGen only)	7501

Control definitions (FinnGen only)

Control exclude: F5_SCHIZO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F20-F29
Name in latin: Schizophrenia

NAME	F5_SCHZPHR
CONTROL_EXCLUDE	F5_SCHIZO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F20
HD_ICD_9	295
HD_ICD_8	295
HD_ICD_10_EXCL
HD_ICD_9_EXCL	2954\|2957
HD_ICD_8_EXCL	2957
COD_MAINONLY
COD_ICD_10	F20
COD_ICD_9	295
COD_ICD_8	295
COD_ICD_10_EXCL
COD_ICD_9_EXCL	2954\|2957
COD_ICD_8_EXCL	2957
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Schizophrenia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	69834	33018	36128
Only index persons	55372	26366	29006
Unadjusted period prevalence (%)
Whole population	0.98	0.95	1.01
Only index persons	1.04	0.97	1.11
Median age at first event (years)
Whole population	33.95	37.21	30.80
Only index persons	32.39	35.12	29.90

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7501	3396	4105
Unadjusted period prevalence (%)	1.51	1.16	1.81
Median age at first event (years)	29.44	30.30	28.74

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7209: Matched controls
72089

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

11.2

323.0

903

907

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

18.5

323.0

629

370

N05AX12

ATC

aripiprazole; systemic

85.1

323.0

2906

566

N06AB04

ATC

citalopram; systemic

5.2

323.0

2842

8064

N06AB06

ATC

sertraline; oral

5.3

323.0

1665

3893

N05CD07

ATC

temazepam; oral

10.9

323.0

2241

2875

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

+∞

323.0

390

SPAT1234

SPAT

Support of social functional capacity

10.8

323.0

856

892

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

72.4

323.0

378

P72

ICPC

Schizophrenia

962.2

323.0

2440

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

5.4

323.0

1190

2550

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2194.8

323.0

1008

F20

ICD-10 Finland

Schizophrenia

10273.0

323.0

911

29580

ICD-8 Finland

Schizophrenia, Other

+∞

323.0

600

F20.9

ICD-10 Finland

Schizophrenia, unspecified

14411.8

323.0

3709

N05BA06

ATC

lorazepam; systemic, sublingual

29.1

323.0

1947

904

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

11465.1

323.0

2375

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

323.0

484

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

+∞

323.0

369

F20.10

ICD-10 Finland

Raise schizophrenia continuously

2987.6

323.0

573

N03AE01

ATC

clonazepam; systemic

6.6

323.0

942

1601

N04AA02

ATC

biperiden; systemic

248.2

323.0

1903

104

N05AA01

ATC

chlorpromazine; systemic, rectal

260.2

323.0

1337

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

+∞

323.0

471

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

+∞

323.0

428

P99

ICPC

Psychological disorders other

21.4

323.0

1037

562

29599

ICD-8 Finland

Schizophrenia, Unspecified type

+∞

323.0

633

N05AD01

ATC

haloperidol; systemic

54.6

323.0

1566

364

T36

ICD-10 Finland

Poisoning by systemic antibiotics

11.3

323.0

1185

1228

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1260.5

323.0

6806

958

F21

ICD-10 Finland

Schizotypal disorder

1846.6

323.0

496

P98

ICPC

Psychosis NOS/other

154.2

323.0

462

N05BA01

ATC

diazepam; systemic, rectal

8.0

323.0

2379

4162

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

12930.0

323.0

3508

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

2746.1

323.0

772

M03BX02

ATC

tizanidine; oral

0.3

323.0

1782

35826

A06AD11

ATC

lactulose; oral

5.4

323.0

1574

3559

N05AX13

ATC

paliperidone; systemic

5710.4

323.0

540

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

+∞

323.0

684

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

24.2

323.0

720

329

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

+∞

323.0

994

N05AH02

ATC

clozapine; systemic

2626.9

323.0

2954

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1939.2

323.0

3106

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

3784.8

323.0

370

F22.0

ICD-10 Finland

Delusional disorder

585.9

323.0

740

N05AH03

ATC

olanzapine; systemic

113.1

323.0

4395

979

N05AC02

ATC

thioridazine; oral

77.5

323.0

1541

252

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

+∞

323.0

997

N05BA04

ATC

oxazepam; oral

4.8

323.0

3006

9283

N05AF03

ATC

chlorprothixene; systemic

87.6

323.0

1970

308

IGY02

NOMESCO Finland

Psychiatric monitoring contact

23.1

323.0

775

374

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2876.7

323.0

1258

F20.8

ICD-10 Finland

Other schizophrenia

2681.0

323.0

520

P29

ICPC

Psychological sympt/compl other

11.2

323.0

1500

1657

N05AH04

ATC

quetiapine; oral

14.5

323.0

4118

6078

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

323.0

799

29510

ICD-8 Finland

Schizophrenia, Hebephrenic type

+∞

323.0

325

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

+∞

323.0

327

N03AG01

ATC

valproic acid; systemic, rectal

19.3

323.0

2130

1534

N05AX08

ATC

risperidone; systemic

80.1

323.0

4091

1164

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

+∞

323.0

1376

P28

ICPC

Limited function/disability (P)

46.5

323.0

405

29530

ICD-8 Finland

Schizophrenia, Paranoid type

+∞

323.0

400

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

1777.0

323.0

481

SPAT1240

SPAT

Therapeutic discussion

4.6

323.0

1558

4109

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

41.5

323.0

437

112

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

+∞

323.0

311

N03AX09

ATC

lamotrigine; oral

8.5

323.0

1026

1375

N05AA02

ATC

levomepromazine; systemic

60.2

323.0

2589

664

F20.0

ICD-10 Finland

Paranoid schizophrenia

11743.9

323.0

1022

N05AF05

ATC

zuclopenthixol; systemic

505.2

323.0

1192

N05AL01

ATC

sulpiride; systemic

25.7

323.0

521

218

29999

ICD-8 Finland

Unspecified psychosis

+∞

323.0

345

N05AE04

ATC

ziprasidone; systemic

109.0

323.0

421

N05AN01

ATC

lithium; oral

27.6

323.0

1046

441

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

+∞

323.0

412

M01AH05

ATC

etoricoxib; oral

0.3

323.0

1629

33067

N05AB03

ATC

perphenazine; systemic, rectal

95.0

323.0

2534

409

N06AB03

ATC

fluoxetine; oral

4.3

323.0

1486

4120

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

16.2

323.0

689

466

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

11.8

323.0

864

819

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

19.6

323.0

834

477

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

18.5

323.0

837

507

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

673.8

323.0

384

F20.5

ICD-10 Finland

Residual schizophrenia

2481.9

323.0

707

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.9

323.0

1358

3287

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

323.0

603

SPAT1222

SPAT

Counselling/guidance promoting independent living

4.1

319.9

1430

4099

N05AE03

ATC

sertindole; oral

654.5

319.5

314

IGV01

NOMESCO Finland

Psychiatric network contact

57.6

317.1

377

IGY99

NOMESCO Finland

Other psychiatric treatment contact

17.4

315.5

512

315

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

19.2

312.5

489

272

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

3019.6

312.4

300

EBA00

NOMESCO Finland

Extraction of tooth

2.7

311.8

3086

15669

N05CF01

ATC

zopiclone; oral

2.8

311.1

2655

12317

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

+∞

309.6

295

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

78.9

297.9

338

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

21.5

297.9

448

221

A28

ICPC

Limited function/disability NOS

4.4

296.8

1201

3114

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

14.1

296.0

523

397

A10BA02

ATC

metformin; oral

2.9

289.0

2204

9426

F20.32

ICD-10 Finland

Undifferentiated schizophrenia stable periodically

2750.1

286.0

275

N07BB01

ATC

disulfiram; oral

6.0

285.5

855

1584

OAB43

SPAT

0.1

283.1

9529

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

11.3

282.8

556

530

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

21.0

282.7

429

217

SPAT1254

SPAT

Administration of medicine

3.7

277.7

1387

4329

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

26.4

276.9

391

156

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.8

274.0

1007

2355

N05AF01

ATC

flupentixol; systemic

16.6

269.5

445

285

29540

ICD-8 Finland

Acute schizophrenia episode

+∞

269.4

257

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

+∞

269.4

257

29570

ICD-8 Finland

Schizophrenia, Schizo-affective type

+∞

263.1

251

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

58.8

261.7

310

F99

ICD-10 Finland

Mental disorder, not otherwise specified

11.5

261.3

508

472

N05BE01

ATC

buspirone; oral

8.9

260.9

585

708

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

63.4

259.7

304

IEV99

NOMESCO Finland

Other psychiatric network intervention

122.8

252.2

272

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.0

246.5

1769

7148

M01AB05

ATC

diclofenac; systemic, rectal

0.4

245.9

2339

38189

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.9

245.8

1836

7611

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

9.1

245.5

541

634

F20.38

ICD-10 Finland

Undifferentiated schizophrenia other definite

2323.1

243.9

235

T90

ICPC

Diabetes non-insulin dependent

2.9

242.4

1821

7566

IGY02

SPAT

36.1

241.9

315

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

+∞

237.8

227

F28

ICD-10 Finland

Other nonorganic psychotic disorders

797.3

236.9

232

F20.03

ICD-10 Finland

Paranoid schizophrenia periodically with gradual improvement

+∞

236.7

226

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

599.8

236.2

233

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

1175.8

234.5

228

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

+∞

233.6

223

J01FA10

ATC

azithromycin; systemic

0.4

233.4

1935

33482

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.3

233.3

1366

4767

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

+∞

231.5

221

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

23.7

231.3

337

149

F20.6

ICD-10 Finland

Simple schizophrenia

2174.9

229.2

221

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.7

228.4

2015

9179

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

+∞

228.3

218

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

+∞

225.2

215

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

+∞

224.1

214

29500

ICD-8 Finland

Schizophrenia, Simple type

+∞

222.0

212

N05AD03

ATC

melperone; systemic

20.8

217.3

330

166

SPAT1307

SPAT

Psychosocial counselling and guidance

4.5

213.7

826

2007

SPAT1243

SPAT

Psychiatric/psychological examination

7.6

213.1

528

744

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.7

212.7

1054

3208

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

16.2

211.2

351

227

F60.9

ICD-10 Finland

Personality disorder, unspecified

14.4

210.2

367

268

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

86.8

209.7

235

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

26.4

208.4

294

116

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

30.3

208.3

283

F10.20

ICD-10 Finland

Alcohol dependence currently independent

9.3

207.8

451

512

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

185.5

207.2

216

F20.33

ICD-10 Finland

Undifferentiated schizophrenia periodically with gradual improvement

+∞

205.2

196

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

683.8

203.3

200

F20.19

ICD-10 Finland

Hebefren schizophrenia UNS

+∞

203.0

194

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

11.7

201.8

387

347

2971A

ICD-9 Finland

Paranoid states, Paranoia

+∞

199.9

191

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

979.5

195.7

191

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.1

189.1

1172

4200

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

7.8

187.4

454

616

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

0.4

185.4

1252

24007

P50

ICPC

Psychological, Medication/prescr/renewal

51.3

184.9

224

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

38.8

182.0

233

IEY01

NOMESCO Finland

Psychoeducation, individual

31.9

179.9

241

30188

ICD-8 Finland

Personality disorders, Alia definita

61.4

177.8

209

N06AX16

ATC

venlafaxine; oral

2.8

177.0

1345

5491

2988A

ICD-9 Finland

Other nonorganic psychoses, Other and unspecified reactive psychosis

+∞

176.8

169

B18.2

ICD-10 Finland

Chronic viral hepatitis C

11.1

176.1

346

325

F25

ICD-10 Finland

Schizoaffective disorders

1822.6

175.6

170

F61.0

ICD-10 Finland

Mixed personality disorders

9.4

173.2

372

413

103

Kela drug reimbursment

Diabetes, insulin-treated

2.3

172.8

1932

9740

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

12.4

170.1

317

267

AA400

NOMESCO Finland

Electroconvulsive therapy

19.9

166.5

256

133

SPAT1301

SPAT

No procedures

2.2

166.1

2267

12511

IEY02

NOMESCO Finland

Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)

139.5

166.0

177

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

9.0

166.0

367

428

C07AA05

ATC

propranolol; systemic

2.4

165.8

1658

7870

F20.20

ICD-10 Finland

Catatonic schizophrenia continuously

1682.7

164.1

159

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

84.0

160.1

180

29830

ICD-8 Finland

Other psychoses, Acute paranoid reaction

+∞

157.9

151

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.3

157.7

1812

9188

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.3

157.2

633

1581

F20.4

ICD-10 Finland

Post-schizophrenic depression

+∞

156.8

150

ICB03

SPAT

109.5

156.8

171

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

30.0

156.7

213

N03AF01

ATC

carbamazepine; oral, rectal

4.7

156.6

571

1292

P73

ICPC

Affective psychosis

41.1

155.1

196

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

13.7

154.8

275

208

F23.20

ICD-10 Finland

Acute schizophrenia-like psychosis without acute stress factor

+∞

154.7

148

K59.09

ICD-10 Finland

Constipation, unspecified

4.6

154.1

574

1327

IER01

NOMESCO Finland

Psychoeducation, group

30.6

153.7

208

29550

ICD-8 Finland

Latent schizophrenia

+∞

153.7

147

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

753.8

150.7

148

EBA30

NOMESCO Finland

Excision of root of tooth

4.3

150.4

607

1518

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

19.8

150.3

231

120

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.3

148.4

289

9662

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.6

148.1

741

2236

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

35.6

146.5

191

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

15.5

146.4

247

165

M01AE01

ATC

ibuprofen; systemic, rectal

0.5

145.8

4993

59415

IEY19

NOMESCO Finland

Psychiatric health counselling and guidance

143.9

145.8

155

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

14.2

144.3

252

183

29560

ICD-8 Finland

Residual schizophrenia

+∞

143.2

137

SPAT1244

SPAT

Occupational therapy

19.7

141.5

218

114

F60.2

ICD-10 Finland

Dissocial personality disorder

46.9

141.4

174

2956C

ICD-9 Finland

Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN]

+∞

141.1

135

N06AX03

ATC

mianserin; oral

4.8

140.8

507

1129

N02AJ06

ATC

codeine and paracetamol; systemic

0.4

139.2

983

19008

N05BA02

ATC

chlordiazepoxide; systemic

6.9

138.3

363

551

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.1

138.2

1973

10927

N06AX11

ATC

mirtazapine; oral

2.0

138.0

2346

13955

Z03

ICPC

Housing/neighbourhood problem

23.1

136.7

200

P27

ICPC

Fear of mental disorder

12.4

136.7

254

212

J01FA09

ATC

clarithromycin; systemic

0.4

136.3

725

15577

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

21.1

136.1

205

100

F20.05

ICD-10 Finland

Paranoid schizophrenia with complete recurrence

+∞

135.8

130

IHZ07

SPAT

36.6

135.1

175

IGP01

NOMESCO Finland

Psychiatric family contact

53.4

134.8

162

D12

ICPC

Constipation

6.7

134.3

358

555

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.5

133.8

697

2164

N06AB05

ATC

paroxetine; oral

3.6

133.7

668

2006

30088

ICD-8 Finland

Neuroses, Other

41.7

132.6

167

R01AD12

ATC

fluticasone furoate; nasal

0.4

132.6

697

15067

K02.1

ICD-10 Finland

Caries of dentine

1.8

132.2

4385

32944

K08.3

ICD-10 Finland

Retained dental root

3.5

131.9

687

2132

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

131.8

954

3720

F23.29

ICD-10 Finland

Acute schizophrenia-like psychosis UNS

1302.3

131.7

128

M01AE02

ATC

naproxen; oral, rectal

0.5

130.6

2030

30771

SPAT1235

SPAT

Mental health, emotional support

16.4

130.6

215

135

N05AC01

ATC

periciazine; systemic

34.8

129.8

170

N06AA04

ATC

clomipramine; systemic

8.6

126.8

286

344

K59.0

ICD-10 Finland

Constipation

4.4

126.7

488

1161

F20.31

ICD-10 Finland

Undifferentiated schizophrenia periodically with gradual deterioration

+∞

126.4

121

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

30.2

126.1

171

IFA99

SPAT

190.5

126.0

131

2953A

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,TARKEMMIN MÄÄRITTE]

+∞

125.3

120

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.5

125.2

651

2014

S10

ICPC

Boil/carbuncle

3.8

122.5

564

1579

R01AD09

ATC

mometasone; nasal

0.5

122.3

1443

23853

2951E

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

+∞

122.2

117

F25.80

ICD-10 Finland

Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms

+∞

122.2

117

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

2.4

121.8

1228

5745

SPAT1241

SPAT

Extensive assessment of psychosocial situation

9.7

121.1

254

269

J01AA02

ATC

doxycycline; systemic

0.6

119.2

3399

44248

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

10.2

118.2

242

245

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

117.9

2142

12896

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

24.0

117.1

169

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.3

117.1

258

8187

29520

ICD-8 Finland

Schizophrenia, Catatonic type

+∞

117.0

112

N05AE05

ATC

lurasidone; oral

49.9

116.9

142

30180

ICD-8 Finland

Personality disorders, Immatura

26.2

116.5

164

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

5.3

115.7

372

729

RS220

NOMESCO Finland

8.8

115.7

257

301

U04

ICPC

Incontinence urine

5.3

115.2

372

733

N05BA12

ATC

alprazolam; oral

2.7

114.2

876

3519

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

8.4

114.0

260

318

N06AA12

ATC

doxepin; systemic

4.0

113.2

480

1248

OAB48

SPAT

0.1

112.9

4456

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.6

112.8

545

1586

N05CD02

ATC

nitrazepam; oral

9.6

110.0

233

251

3012C

ICD-9 Finland

Personality disorders, Schizoid personality disorder[PSYKOOSIPIIRTEINEN PERSOONALLISUUS]

1084.7

109.7

107

OAA65

SPAT

0.2

107.9

4585

30041

ICD-8 Finland

Neuroses, Depressiva

12.0

107.9

203

174

N02AX02

ATC

tramadol; systemic, rectal

0.5

107.5

1132

19555

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.9

106.4

370

790

M01AC06

ATC

meloxicam; systemic, rectal

0.5

106.2

911

16797

P01

ICPC

Feeling anxious/nervous/tense

2.5

105.5

909

3888

SPAT1252

SPAT

Overall medication plan or its review

3.5

105.2

536

1625

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.8

105.2

374

818

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

48.2

104.8

128

L17

ICPC

Foot/toe symptom/complaint

2.0

104.8

1639

9243

N06AB08

ATC

fluvoxamine; oral

5.4

104.7

334

648

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

22.3

102.5

151

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.5

102.0

278

443

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

20.0

101.5

155

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.5

101.2

276

440

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.0

101.0

636

2247

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

6.7

101.0

268

412

N05AX15

ATC

cariprazine; oral

153.6

100.4

106

R06AX27

ATC

desloratadine; oral

0.4

100.3

655

13282

F20.14

ICD-10 Finland

Hepatic schizophrenia with partial recurrence

+∞

100.2

C07AB07

ATC

bisoprolol; oral

1.8

100.0

2618

17615

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

34.2

99.8

131

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

68.6

99.8

115

A46

ICD-10 Finland

Erysipelas

2.4

99.5

980

4491

IEZ99

NOMESCO Finland

Other psychiatric rehabilitation intervention

59.4

99.3

117

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.6

99.2

801

3300

F23.00

ICD-10 Finland

Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor

+∞

99.2

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

6.5

98.7

267

421

H13

ICPC

Plugged feeling ear

2.2

98.7

1131

5573

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.3

98.4

385

926

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

14.2

98.3

171

123

WX290

NOMESCO Finland

Other blockade of nerve

1.7

98.1

3469

25495

N05AB01

ATC

dixyrazine; systemic

9.4

97.0

207

226

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.5

94.9

358

831

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

8.4

94.6

216

265

RS140

NOMESCO Finland

44.0

94.2

117

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

26.3

94.1

132

F20.35

ICD-10 Finland

Undifferentiated schizophrenia with complete recurrence

930.4

94.1

F25.81

ICD-10 Finland

Other specified schizoaffective disorder with prolonged schizophrenic than bipolar symptoms

+∞

93.9

P19

ICPC

Drug abuse

8.9

93.2

205

236

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.0

93.1

1524

8687

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.7

92.7

3848

29396

F23.91

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

463.6

92.5

N05AA03

ATC

promazine; systemic

76.2

92.4

105

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.3

92.3

220

6776

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

51.2

91.9

111

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.4

91.7

449

10154

SPAT1251

SPAT

Organisation of medication

4.6

91.7

334

748

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

70.9

91.6

105

R44.3

ICD-10 Finland

Hallucinations, unspecified

42.8

91.3

114

29899

ICD-8 Finland

Other psychoses, Reactive psychosis, unspecified

101.4

91.1

100

P15

ICPC

Chronic alcohol abuse

4.2

90.5

363

894

R53

ICD-10 Finland

Malaise and fatigue

2.0

90.0

1340

7353

R41.0

ICD-10 Finland

Disorientation, unspecified

6.1

89.9

257

436

OAA67

SPAT

0.1

89.4

3717

IFC99

NOMESCO Finland

Other biological psychiatric intervention

109.2

89.1

F39

ICD-10 Finland

Unspecified mood [affective] disorder

6.2

89.0

249

411

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.9

87.9

387

1037

29820

ICD-8 Finland

Other psychoses, Reactive confusion

+∞

87.7

F61

ICD-10 Finland

Mixed and other personality disorders

16.6

87.6

143

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

24.4

87.3

125

G72.8

ICD-10 Finland

Other specified myopathies

8.4

87.2

199

244

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

60.8

87.0

102

F23.9

ICD-10 Finland

Acute and transient psychotic disorder, unspecified

299.0

86.9

R44.0

ICD-10 Finland

Auditory hallucinations

37.6

86.5

111

-1

NOMESCO Finland

1.7

86.2

2473

16897

R01BA52

ATC

pseudoephedrine, combinations; oral

0.5

85.9

767

14124

N05AL05

ATC

amisulpride; oral

+∞

85.6

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

15.7

85.3

142

ICZ04

NOMESCO Finland

Preparation of psychiatric treatment plan

81.1

85.3

N06AA09

ATC

amitriptyline; systemic

2.6

85.2

698

2886

K04.7

ICD-10 Finland

Periapical abscess without sinus

3.0

85.1

536

1886

IEV99

SPAT

80.3

84.3

G04BD04

ATC

oxybutynin; oral, transdermal

3.7

83.9

397

1130

F10.24

ICD-10 Finland

Alcohol depence active use

6.4

83.5

230

372

F05.9

ICD-10 Finland

Delirium, unspecified

8.1

83.2

194

246

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

15.5

83.2

139

H81

ICPC

Excessive ear wax

2.2

82.8

973

4818

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

7.2

82.6

207

293

RT250

NOMESCO Finland

52.8

82.5

IHZ04

SPAT

16.1

82.5

136

F20.29

ICD-10 Finland

Catat schizophrenia UNS

+∞

82.4

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

13.3

82.2

147

113

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

82.0

675

2797

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

8.4

81.7

186

227

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

0.2

81.6

112

4598

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.0

81.6

502

1739

A29

ICPC

General symptom/complaint other

2.4

81.4

743

3252

X78

ICD-10 Finland

Intentional self-harm by sharp object

15.4

81.0

136

T82

ICPC

Obesity

3.7

81.0

377

1058

F23.10

ICD-10 Finland

Acute polymorphic psychosis with schizophrenic disease picture without acute stress factor

+∞

80.3

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

10.5

80.1

160

155

IEY06

NOMESCO Finland

Psychiatric treatment and rehabilitation coaching

49.1

79.8

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

79.8

3431

26018

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

79.6

835

3914

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.2

79.3

958

4794

N05AB02

ATC

fluphenazine; systemic

18.5

79.3

124

M03BC01

ATC

orphenadrine (citrate); systemic

0.5

79.3

580

11429

SPAT1260

SPAT

Consultation of another employee

2.0

79.3

1164

6317

N05BA05

ATC

potassium clorazepate; oral

12.2

79.1

147

123

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

141.6

79.1

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

78.7

5000

41852

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

4.4

78.5

299

700

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.7

78.3

584

2283

M03BC51

ATC

orphenadrine, combinations; systemic

0.5

78.2

735

13374

WX110

NOMESCO Finland

Local anesthesy

1.6

78.2

4860

40401

IAB12

NOMESCO Finland

Psychiatric psychosis consultation

391.6

78.0

KMAK

NOMESCO Finland

1.6

77.4

3793

29636

29700

ICD-8 Finland

Paranoid states, Paranoia

+∞

77.2

Z08

ICPC

Social welfare problem

7.5

76.8

187

254

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

75.8

845

4071

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

32.7

75.6

100

OAA80

SPAT

0.1

75.0

2658

C03CA01

ATC

furosemide; systemic

1.9

74.8

1281

7351

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.3

74.4

239

467

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

22.1

74.0

109

A04

ICPC

Weakness/tiredness general

2.2

74.0

810

3869

AA1AD

NOMESCO Finland

CT of head and brain

1.9

74.0

1363

8023

OAB95

SPAT

0.1

73.9

2393

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

73.8

2555

18186

S29

ICPC

Skin symptom/complaint other

2.0

73.7

1067

5742

Z72.2

ICD-10 Finland

Drug use

10.7

73.3

145

138

2959B

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,SUBKROONINEN]

+∞

73.0

N06AG02

ATC

moclobemide; oral

3.4

72.9

377

1151

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.4

72.5

646

2786

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

72.3

630

2686

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

20.5

72.2

109

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

40.1

72.1

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

31.4

71.9

GD1AA

SPAT

0.2

71.8

3103

F60.0

ICD-10 Finland

Paranoid personality disorder

21.9

71.8

106

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

16.5

71.8

117

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

13.0

71.6

129

101

S22

ICPC

Nail symptom/complaint

3.1

71.2

428

1457

N05AE02

ATC

molindone; oral

695.0

70.2

29800

ICD-8 Finland

Other psychoses, Reactive depressive psychosis

+∞

69.9

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

36.4

69.8

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.9

69.8

446

1581

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

7.2

69.2

174

248

N05AX16

ATC

brexpiprazole; oral

86.5

69.0

N06AB10

ATC

escitalopram; oral

1.8

68.9

1465

9018

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

2.3

68.4

708

3287

31099

ICD-8 Finland

Borderline mental retardation, Other and unspecified

71.5

68.3

2956E

ICD-9 Finland

Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

+∞

67.8

IGY99

SPAT

9.2

67.7

145

160

SPAT1197

SPAT

Extensive health check-up of expecting family

0.2

67.4

3765

R3540

NOMESCO Finland

Rehabilitative work activities

232.1

67.3

V03AA01

ATC

5.5

66.9

206

383

N06AX05

ATC

trazodone; oral

4.3

66.3

257

612

P55

ICPC

Psychological, Local injection/infiltration

654.1

66.0

IFA01

SPAT

141.3

66.0

2967A

ICD-9 Finland

Affective psychoses, Bipolar affective disorder, unspecified

141.3

66.0

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

8.7

65.9

146

171

F23.2

ICD-10 Finland

Acute schizophrenia-like psychotic disorder

+∞

65.7

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.5

65.5

486

9596

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

65.0

2747

20371

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.3

65.0

156

4824

R33

ICD-10 Finland

Retention of urine

2.8

65.0

436

1594

2959D

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,SUBKROONINEN AKUUTTI]

+∞

64.7

F60.8

ICD-10 Finland

Other specific personality disorders

9.7

64.5

134

140

K03.66

ICD-10 Finland

Tooth plaque

2.7

64.2

479

1869

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

54.8

63.9

F20.12

ICD-10 Finland

Hebefren schizophrenia stable periodically

+∞

63.6

Z10.0

ICD-10 Finland

Occupational health examination

0.2

63.5

2742

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.9

63.5

403

1420

R95

ICPC

Chron obstructive pulmonary disease

5.0

63.2

212

435

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

63.1

4519

37731

F12.5

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, psychotic disorder

166.5

63.0

2953D

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,SUBKROON AKUUTTI]

+∞

62.6

F2090

ICD-10 Finland

+∞

62.6

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.3

62.4

111

3984

F60.1

ICD-10 Finland

Schizoid personality disorder

18.0

62.3

F19.50

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic

215.2

62.2

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.3

61.9

126

4222

F93.89

ICD-10 Finland

Other childhood emotional disorders

11.8

61.7

116

100

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

40.9

61.4

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.0

61.3

143

182

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

61.3

405

1465

9693X

ICD-9 Finland

Poisoning by psychotropic agents, Other antipsychotics, neuroleptics and major tranquillisers

161.4

61.0

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.6

60.6

857

14036

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.9

60.6

208

438

F22.8

ICD-10 Finland

Other persistent delusional disorders

310.2

60.4

H02AB06

ATC

prednisolone; systemic

0.6

60.4

1558

22115

SPAT1310

SPAT

Counselling related to known health issue

1.6

60.2

1963

13578

RT150

NOMESCO Finland

28.6

60.1

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.8

60.0

268

726

SPAT1262

SPAT

Handing over of treatment supplies

1.8

59.9

1107

6471

30120

ICD-8 Finland

Personality disorders, Schizoid

129.1

59.9

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

58.8

3776

30534

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

21.5

58.7

P74

ICPC

Anxiety disorder/anxiety state

3.1

58.7

341

1131

30099

ICD-8 Finland

Neuroses, Unspecified neurosis

29.6

58.5

P17

ICPC

Tobacco abuse

5.7

58.3

174

312

Z02.4

ICD-10 Finland

Examination for driving licence

0.4

58.1

338

7277

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

1963

8242

2.87

316.28

1.9

1.7

1201.1

1155.6

nmol/l

1.37

1529

6399

(3001604) Monocytes [#/volume] in Blood

4727

29380

2.65

307.65

14.4

5.9

0.6

e9/l

15.47

4186

25684

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3889

20155

2.93

307.65

4.2

3.2

29.6

34.4

u/l

4.66

3660

19208

(3009466) Valproate [Moles/volume] in Serum or Plasma

1423

571

30.52

307.65

7.4

4.0

390.9

361.1

umol/l

4.55

1297

495

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

637

249

27.86

307.65

14.5

9.8

0.6

mmol/l

3.96

589

225

(3013115) Eosinophils [#/volume] in Blood

4884

30520

2.72

307.65

20.1

6.0

0.2

e9/l

53.02

4416

27101

(3028707) Methadone [Presence] in Urine by Screen method

868

1261

7.65

307.65

6.1

2.8

—

(4198724)

420

297

14.92

307.65

3.6

2.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

5419

33709

3.19

307.65

39.6

8.3

4.5

4.0

e9/l

45.00

5013

29565

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

937

267.55

307.65

2.7

1.9

163.2

124.9

nmol/l

2.33

808

(3006315) Basophils [#/volume] in Blood

4749

29480

2.67

307.65

14.7

5.9

0.0

e9/l

25.88

4198

25768

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2202

9535

2.85

307.65

2.7

1.8

1.6

1.4

35.02

1981

8557

(3019198) Lymphocytes [#/volume] in Blood

4788

30436

2.58

307.65

15.1

5.9

2.0

e9/l

3.75

4251

27147

(40758558) Short blood count panel - Blood

2823

14492

2.52

300.98

21.3

6.5

—

(3011288) Drugs identified in Urine by Screen method

858

2259

4.16

290.43

7.8

2.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

948

2710

3.86

285.89

5.8

2.0

—

(42870588) Differential panel, method unspecified - Blood

3373

19492

2.33

267.76

10.3

6.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1428

5485

2.98

266.50

2.0

1.7

—

(3019069) Monocytes/100 leukocytes in Blood

4316

27715

2.31

265.79

15.3

6.3

8.2

8.6

11.11

4069

26185

(3022096) Basophils/100 leukocytes in Blood

4195

26722

2.29

261.92

14.2

6.1

0.5

0.7

72.24

3950

25120

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1813

7993

2.67

259.60

2.1

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1398

5421

2.94

255.60

2.0

1.7

—

(3006504) Eosinophils/100 leukocytes in Blood

4267

27567

2.27

254.78

14.2

6.1

2.1

2.9

111.91

4014

25884

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5910

44124

2.60

248.74

6.8

7.5

80.3

76.0

u/l

8.54

5651

41838

(3002030) Lymphocytes/100 leukocytes in Blood

4344

28746

2.21

238.00

14.6

6.1

28.0

28.8

4.62

4081

27033

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4003

25655

2.20

237.63

6.3

7.0

1.2

mmol/l

6.08

3292

21763

(3018010) Neutrophils/100 leukocytes in Blood

4286

28317

2.20

234.33

14.3

5.9

58.6

56.6

24.18

4011

26732

(3023368) Bacteria identified in Blood by Culture

2571

13888

2.30

231.73

4.8

4.3

—

(3016879) Cocaine [Presence] in Urine

990

3359

3.24

226.74

6.1

1.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3693

23234

2.16

225.98

5.8

6.3

1.2

mmol/l

2.01

3386

21238

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

167

20.56

219.51

2.1

15.9

15.6

umol/l

0.08

167

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5885

44983

2.43

215.47

5.0

3.7

14.6

14.7

pmol/l

0.55

5522

41497

(3015377) Calcium [Moles/volume] in Serum or Plasma

2955

17288

2.17

215.13

2.6

3.4

2.3

2.4

mmol/l

0.82

2646

15402

(3021960) Folate [Moles/volume] in Serum or Plasma

2120

10856

2.33

213.84

1.6

1.5

18.3

20.2

nmol/l

7.88

1959

9489

(3018418) pH of Serum or Plasma

2682

15148

2.20

213.05

3.4

4.3

7.4

0.64

525

2999

(3026008) Bacteria identified in Urine by Culture

2457

13409

2.24

212.46

3.9

2.8

—

(3009508) Creatinine [Moles/volume] in Urine

2929

17235

2.15

208.51

4.5

3.2

7.0

8.4

mmol/l

23.96

2509

14829

(3000764) Benzodiazepines [Presence] in Urine

1002

3599

3.06

207.31

6.1

1.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2064

10629

2.30

203.98

1.8

1.6

50648318.1

30793343.5

pmol/l

0.55

1775

9093

(3019150) Specific gravity of Urine by Refractometry

2238

11943

2.25

202.79

5.8

3.5

1.0

kg/l

1.75

340

1663

(3027008) Opiates [Presence] in Urine

999

3627

3.02

202.57

6.1

1.8

—

(3028300) Cannabinoids [Presence] in Urine

1000

3634

3.02

202.44

6.2

1.9

—

(3027944) Amphetamines [Presence] in Urine

972

3575

2.97

192.08

6.2

1.8

—

(21494755) Public health laboratory ask at order entry panel

9342

0.08

191.17

1.2

1.3

—

(3044889) 12 lead EKG panel

5388

40696

2.15

186.93

4.8

3.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3214

20384

2.01

179.50

2.1

1.8

94.5

97.0

pmol/l

2.57

1732

10916

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6563

54245

2.68

177.36

6.6

4.3

1.9

2.3

mu/l

2.23

6259

50466

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2853

17571

2.01

171.07

2.8

2.7

46.6

57.7

u/l

55.87

2614

16365

(3013826) Glucose [Moles/volume] in Serum or Plasma

4434

32612

1.88

147.69

5.7

4.7

6.9

6.7

mmol/l

6.89

4099

30453

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

779

2914

2.87

147.53

1.8

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

7910

0.11

145.07

1.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

7012

61339

3.20

144.07

21.3

13.4

139.5

139.7

mmol/l

7.48

6915

59831

(1761868) Lipid panel - Serum or Plasma

1511

25849

0.48

138.30

3.6

2.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

7013

61616

3.12

137.65

21.1

13.5

4.0

mmol/l

2.92

6915

59987

(3021387) Prolactin [Units/volume] in Serum or Plasma

666

2386

2.97

136.11

2.2

1.7

675.0

264.1

mu/l

32.84

570

2183

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6722

58014

2.53

133.30

6.7

3.9

6.3

5.9

mmol/l

103.24

6413

53924

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3985

29004

1.80

130.37

5.0

6.3

8.9

11.3

umol/l

22.10

3738

27586

(3031040) Bacteria [#/volume] in Urine by Automated count

4669

35642

1.82

129.91

5.7

3.8

1744.5

1308.0

e6/l

0.20

109

440

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3292

22726

1.80

128.02

2.6

2.2

68.3

75.1

nmol/l

35.75

3092

20942

(3021589) Normoblasts [#/volume] in Blood

3652

26141

1.77

124.23

17.0

9.0

0.0

e9/l

1.92

2993

21517

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2379

15054

1.85

121.85

1.8

1.6

1.7

1.4

mmol/l

28.19

2134

12868

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

239

450

5.45

120.40

2.0

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

755

3102

2.59

118.02

8.0

7.6

26.2

24.4

mmol/l

20.51

705

2883

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6406

55026

2.12

114.24

7.5

5.0

39.9

39.1

mmol/mol

7.50

6094

51847

(3024561) Albumin [Mass/volume] in Serum or Plasma

3288

23234

1.74

113.59

4.1

5.2

35.2

36.3

g/l

21.24

3028

21765

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2481

16250

1.79

111.20

3.0

2.1

458.8

221.1

u/l

5.04

2322

15365

(3021447) Carbon dioxide [Partial pressure] in Venous blood

971

4602

2.28

110.24

3.5

4.0

6.0

5.8

kpa

6.25

917

4470

(3002032) Base excess in Venous blood by calculation

961

4576

2.26

107.74

3.6

4.0

2.6

1.8

mmol/l

7.31

774

3727

(3042517) Benzodiazepines panel - Urine

13.92

107.40

3.1

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

194

350

5.66

102.31

3.6

2.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

818

3717

2.35

102.10

3.2

3.3

4.9

4.7

kpa

2.22

769

3597

(3012544) pH of Venous blood

970

4769

2.19

100.08

3.4

4.0

7.4

—

(3015736) pH of Urine

3041

21571

1.69

99.54

4.9

3.0

—

5.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2416

16107

1.74

99.33

3.9

4.1

7.9

9.5

mg/mmol

0.70

1499

10622

(44816559) Phosphatidylethanol [Mass/volume] in Blood

413

1360

3.16

97.08

1.5

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

966

4805

2.16

96.57

8.5

4.1

0.8

0.9

0.32

338

1290

(40760892) CBC W Ordered Manual Differential panel - Blood

2159

14041

1.75

96.33

12.0

4.2

—

(3003396) Base excess in Arterial blood by calculation

1100

5777

2.06

95.19

7.3

8.4

2.5

0.9

mmol/l

27.04

885

4504

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

5288

0.11

94.93

1.6

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

174

312

5.69

92.36

1.8

1.6

3352143.6

1905978.6

iu/ml

0.52

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

250

8105

0.28

92.08

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

155

254

6.21

90.26

4.0

1.7

126.5

137.2

umol/l

0.16

126

(3012516) Albumin [Mass/volume] in Urine

2286

15345

1.70

89.73

3.2

3.4

345.3

416.3

mg/l

0.30

1406

10004

(3029937) Albumin [Presence] in Urine by Test strip

2193

14614

1.71

88.11

5.0

3.6

0.0

estimate

3.03

635

5077

(3016502) Oxygen saturation in Arterial blood

992

5159

2.06

87.67

7.5

8.9

94.2

96.0

16.21

953

4982

(3019060) Gas panel - Arterial blood

710

3245

2.31

86.85

5.7

5.3

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

188

388

4.94

85.28

4.2

2.8

—

28.0

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1071

5797

1.99

84.45

7.3

8.3

10.4

12.9

kpa

48.64

1012

5549

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1071

5799

1.99

84.36

7.3

8.3

5.5

5.1

kpa

18.94

1012

5550

(3023511) Choriogonadotropin [Units/volume] in Urine

325

1030

3.25

81.28

1.8

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

926

4822

2.05

81.16

7.7

9.4

123.6

123.7

g/l

0.02

885

4653

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

612

2759

2.33

76.99

1.9

1.6

—

(3017509) Phencyclidine [Presence] in Urine

10.35

76.47

3.8

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

4064

0.10

75.47

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5301

44830

1.62

75.12

5.0

3.0

46.1

47.1

u/l

0.37

5027

42568

(3008295) Osmolality of Serum or Plasma

208

520

4.09

74.08

1.7

1.4

283.7

280.7

mosm/kgh2o

0.80

158

410

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1894

12630

1.67

73.48

2.3

2.2

2.8

mg/l

0.04

1648

10917

(3020191) Ethanol [Moles/volume] in Serum or Plasma

214

568

3.85

70.14

1.9

1.5

0.7

1.6

promille

13.95

159

435

(40768804) Tissue Pathology biopsy report

1592

23340

0.60

69.96

1.9

2.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

861

4595

1.99

69.86

6.0

8.0

1.4

1.3

mmol/l

1.68

818

4430

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

116

187

6.28

68.68

1.5

73.7

73.3

0.09

104

182

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

114

182

6.34

68.14

1.5

892.3

365.1

mu/l

6.42

102

177

(3026782) Osmolality of Urine

1591

10312

1.69

68.02

2.8

2.7

481.9

561.6

mosm/kgh2o

33.99

1367

8838

(3021440) Promyelocytes/100 leukocytes in Blood

854

4601

1.97

67.29

9.4

4.1

0.1

0.2

1.68

285

1201

(3015235) Bicarbonate [Moles/volume] in Capillary blood

341

1240

2.83

66.95

3.7

2.9

26.5

24.5

mmol/l

10.12

320

1078

(3002179) Metamyelocytes/100 leukocytes in Blood

824

4417

1.97

65.81

7.6

4.0

0.5

0.6

0.30

183

965

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

103

8.34

64.98

1.1

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

626

3056

2.14

64.48

3.2

3.4

130.9

131.7

g/l

0.33

610

2987

(3037467) Urinalysis macro (dipstick) panel - Urine

4663

38918

1.52

64.05

4.9

3.9

—

(3047181) Lactate [Moles/volume] in Blood

402

1625

2.56

64.04

7.0

6.6

1.3

mmol/l

0.01

352

1425

(3027273) Bicarbonate [Moles/volume] in Venous blood

509

2292

2.31

63.91

3.6

25.9

25.2

mmol/l

4.02

490

2219

(3011397) Hemoglobin [Presence] in Urine by Test strip

1852

12666

1.61

63.41

4.4

3.3

—

(3002385) Erythrocyte distribution width [Ratio]

5890

52073

1.61

59.91

40.1

14.3

13.8

13.5

41.23

5792

51037

(3040151) Glucose [Moles/volume] in Capillary blood

189

530

3.63

57.20

22.7

17.0

7.3

7.4

mmol/l

0.03

158

450

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

467

2136

2.27

56.37

4.2

3.9

55.6

49.9

4.90

459

2112

(3003181) Sodium [Moles/volume] in Urine

237

774

3.13

56.31

1.4

53.8

64.4

mmol/l

3.21

164

613

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

491

2310

2.20

55.32

3.1

3.0

0.7

0.08

468

2217

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

506

9779

0.48

54.88

1.2

1.3

9.6

10.7

u/ml

0.14

149

4036

(3023183) Ammonium ion [Moles/volume] in Plasma

307

1172

2.69

54.84

1.7

3.2

30.3

36.5

umol/l

4.10

256

1033

(3027945) Reticulocytes/100 erythrocytes in Blood

897

5230

1.81

54.69

4.0

2.6

1.8

0.20

787

4703

(3035350) Ketones [Presence] in Urine by Test strip

3489

27976

1.46

54.54

4.5

3.2

0.0

estimate

1.08

653

5115

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

566

10389

0.51

52.28

1.2

1.3

24.7

32.1

iu/ml

0.90

147

3281

(3025159) Blasts/100 leukocytes in Blood

772

4371

1.85

51.62

10.0

4.2

0.1

0.2

0.72

198

1032

(3021901) Oxygen saturation in Capillary blood

247

870

2.90

51.39

3.2

2.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

397

1766

2.32

51.11

4.7

4.3

1.3

1.4

mmol/l

0.21

387

1741

(3000991) Gas panel - Venous blood

763

4332

1.85

50.52

6.8

9.7

—

(3009261) Glucose [Presence] in Urine by Test strip

3495

28303

1.44

50.29

4.5

3.3

0.0

estimate

0.12

646

5072

(3002582) Erythrocytes [#/volume] in Urine

2202

16344

1.49

49.84

3.4

3.1

96.0

88.5

e6/l

0.07

1737

12493

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

668

11481

0.54

49.47

2.0

2.6

0.5

0.7

ug/l

11.14

466

6515

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

226

783

2.94

48.45

2.3

1.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1043

6554

1.69

48.43

7.0

8.0

103.4

104.5

mmol/l

8.47

990

6426

(1616796) Gas panel - Central venous blood

293

1167

2.57

48.03

4.4

3.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

272

1049

2.65

47.60

3.3

2.7

8.0

8.3

kpa

3.01

265

958

(3026493) Urate [Moles/volume] in Serum or Plasma

1022

15538

0.60

47.56

2.2

2.5

2237.9

3550.8

umol/l

0.91

842

13839

(3021601) Nitrite [Presence] in Urine by Test strip

3449

28055

1.42

47.36

5.7

4.4

0.0

estimate

0.80

660

5294

(3018095) Leukocytes [#/volume] in Urine

2508

19265

1.45

46.99

3.9

3.5

84.3

74.2

e6/l

0.42

1830

13565

(3020891) Body temperature

428

2038

2.17

46.66

6.1

5.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1319

8886

1.59

46.12

2.6

3.0

2.4

mmol/l

0.88

1131

7803

(3006184) Hemoglobin [Mass/volume] in Capillary blood

279

1109

2.57

45.93

2.6

2.3

130.8

132.7

g/l

0.63

251

787

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1303

8766

1.59

45.80

2.5

3.8

0.8

mmol/l

3.91

1186

8271

(3043409) Potassium [Moles/volume] in Arterial blood

345

1517

2.34

45.58

4.8

4.6

3.8

3.9

mmol/l

1.15

307

1434

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

489

2478

2.04

45.22

3.3

4.2

24.6

24.2

mmol/l

1.92

407

2236

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

720

4166

1.81

44.58

3.5

4.0

1.2

mmol/l

1.57

623

3689

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2601

20302

1.43

43.92

4.2

3.1

37.3

74.9

ng/l

0.73

1833

12188

(3000850) Epithelial cells [#/volume] in Urine

1582

11210

1.52

43.84

2.7

2.5

8.0

5.2

e6/l

9.41

1406

9880

(3007930) Methemoglobin/Hemoglobin.total in Blood

412

1989

2.13

43.33

6.4

5.7

0.9

0.86

384

1864

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

412

2003

2.12

42.54

6.2

5.7

2.1

1.7

4.89

383

1875

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

397

1914

2.13

41.88

2.2

2.0

2.3

2.0

ug/l

0.18

360

1729

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1055

6921

1.61

40.80

4.1

6.7

1.0

mmol/l

0.01

967

6524

(3010421) pH of Blood

321

1463

2.25

38.95

5.2

4.1

7.4

0.55

254

1239

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

515

2818

1.89

37.96

9.1

11.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

149

5.21

37.71

1.4

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2748

22087

1.39

37.52

5.0

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1969

14984

1.43

36.83

3.2

3.0

0.5

0.4

e6/l

0.83

1518

11198

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

224

4.28

36.68

2.2

3.3

—

(3039000) Anion gap in Blood

262

1148

2.33

34.89

8.2

7.9

10.4

11.4

mmol/l

4.06

242

1030

(3018572) Chloride [Moles/volume] in Blood

262

1149

2.33

34.82

8.2

7.9

105.0

105.1

mmol/l

0.12

242

1031

(3004809) Band form neutrophils/100 leukocytes in Blood

211

844

2.54

34.32

2.7

3.3

1.1

1.4

0.91

151

660

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

528

3009

1.81

34.11

3.5

3.3

3.1

1.6

mmol/l

13.81

408

2237

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

550

3175

1.79

34.04

3.6

3.3

5.5

5.2

kpa

11.08

531

2950

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2642

0.24

33.58

1.4

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

143

5.00

33.26

4.4

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

143

5.00

33.26

4.4

2.5

—

(3009343) pH of Capillary blood

541

3130

1.79

33.21

3.6

3.3

7.4

1.10

106

400

(3017732) Neutrophils [#/volume] in Blood

678

4180

1.68

33.16

12.8

2.3

4.4

4.1

e9/l

2.83

584

3413

(40767503) Oxygen content in Capillary blood by calculation

252

1121

2.29

32.41

3.5

2.4

16.5

16.9

0.71

152

539

(3007853) Bacteria identified in Skin by Aerobe culture

986

6694

1.54

32.32

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6644

62439

1.56

32.01

5.9

4.3

2.6

2.9

mmol/l

109.37

6300

58718

(3023520) Reticulocytes [#/volume] in Blood

622

3785

1.70

31.90

2.0

2.8

73.9

71.6

e9/l

0.82

477

2837

(3039443) Prostate specific Ag panel - Serum or Plasma

1702

0.09

31.65

1.3

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6973

66364

1.72

31.25

12.3

9.5

29.2

29.0

u/l

0.24

6835

64480

(36304419) Bacteria [Presence] in Urine

1901

14794

1.38

30.07

3.2

2.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1388

10244

1.44

29.80

3.8

3.4

254.9

577.1

ng/l

1.83

928

7333

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

814

5385

1.57

29.79

5.1

3.1

—

(3037522) Nuclear Ab [Titer] in Serum

537

8641

0.59

29.55

1.3

1.4

542.3

526.3

titre

0.05

1634

(3000492) Spirometry study

399

6952

0.55

29.50

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2173

26633

0.74

28.93

4.1

3.9

—

(3019977) pH of Arterial blood

259

3.62

28.59

4.5

2.4

7.4

0.11

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1665

12768

1.39

28.55

2.5

3.0

1036.0

1145.4

ng/l

0.36

1358

10673

(3012501) Base excess in Blood by calculation

261

1258

2.11

27.55

5.3

4.0

3.3

2.3

mmol/l

4.23

205

865

(3027315) Oxygen [Partial pressure] in Blood

262

1265

2.11

27.53

5.3

4.0

8.3

8.9

kpa

6.39

255

1244

(3013290) Carbon dioxide [Partial pressure] in Blood

261

1259

2.11

27.49

5.3

4.0

5.4

5.0

kpa

6.75

254

1239

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4085

45746

0.76

27.46

3.1

3.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

230

1063

2.20

27.01

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

230

1063

2.20

27.01

1.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

987

6974

1.48

26.36

1.4

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

345

1865

1.89

26.32

2.3

2.5

888.0

581.7

ug/l

0.76

312

1767

(1002224) Polysomnography panel

156

3561

0.43

25.49

1.1

—

(40761535) Cells panel - Urine sediment

649

4254

1.58

24.54

3.6

3.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6531

61745

1.45

24.47

5.4

4.0

4.4

4.8

mmol/l

160.85

6201

58424

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

591

3796

1.60

24.36

1.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

7.09

24.13

1.4

1.3

56.8

41.3

mg/l

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

240

1185

2.06

23.80

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

392

6482

0.58

23.63

2.1

2.3

11.1

13.9

nmol/l

10.72

337

5906

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

266

1372

1.97

23.35

1.3

—

(4035726)

255

4739

0.52

23.17

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1396

0.15

22.83

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1395

0.15

22.81

1.1

—

(3002256) Pathology report gross observation

456

7200

0.61

22.80

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

208

3.58

22.52

2.8

2.7

28.4

29.0

umol/l

0.12

148

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6305

59418

1.38

22.46

4.7

3.6

1.6

1.3

mmol/l

97.95

5919

55798

(3008898) HLA-B27 [Presence]

2505

0.36

22.36

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1701

0.24

21.80

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

782

5487

1.47

21.40

2.4

2.6

27.2

51.2

u/l

2.01

650

4769

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1005

13374

0.71

21.23

2.3

—

(3007463) Buprenorphine [Presence] in Urine

10.03

21.14

4.2

6.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6490

61601

1.40

20.88

18.4

12.3

25.3

22.7

mg/l

7.94

5553

47855

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1506

0.22

20.78

1.3

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

126

511

2.49

20.06

3.2

3.1

27.9

58.4

mg/l

1.17

382

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

911

6665

1.42

19.85

2.1

2.9

7.4

7.8

umol/l

0.16

683

5858

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6463

61412

1.38

19.68

5.2

4.0

1.3

1.4

mmol/l

232.32

6124

57904

(3042936) Bacteria identified in Isolate by Culture

1072

8078

1.38

19.62

2.0

2.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1398

0.21

19.54

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1397

0.21

19.52

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1396

0.21

19.49

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1392

0.21

19.41

1.3

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

682

4750

1.48

19.30

4.5

8.7

8.2

9.0

mmol/l

2.61

648

4557

(4094501)

1705

0.29

19.25

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

366

2216

1.69

19.03

2.8

2.4

5066.5

4986.9

u/l

0.01

862

(3024928) Oxygen saturation in Venous blood

222

1157

1.95

18.97

1.9

3.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1126

8606

1.36

18.80

1.8

1.7

—

(3022145) Colonoscopy Study observation

442

6730

0.64

18.67

1.3

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1385

17260

0.76

18.50

1.3

1.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

11.20

17.98

1.7

1.3

488.1

552.6

nmol/l

0.13

(3045716) Anion gap in Serum or Plasma

225

3.18

17.98

1.9

2.6

8.2

9.7

mmol/l

1.98

171

(3044242) Glucose [Moles/volume] in Arterial blood

227

3.15

17.72

3.1

1.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

169

819

2.09

17.71

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1909

0.36

17.61

1.2

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

251

1397

1.82

17.53

1.9

1.8

—

(3013727) Leukocytes other/100 leukocytes in Blood

156

3.61

17.35

2.7

3.3

58.4

51.9

1.81

151

(3009542) Hematocrit [Volume Fraction] of Blood

5619

59410

0.78

17.33

37.7

12.4

39.6

41.1

18.08

3289

47267

(3044640) Blood type and Crossmatch panel - Blood

1421

17522

0.77

17.31

2.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

390

2.56

16.82

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

231

1273

1.84

16.68

1.4

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

523

3572

1.50

16.26

2.0

3.5

4.4

4.5

pmol/l

3.35

427

3212

(3016038) Potassium [Moles/volume] in Urine

300

2.75

16.14

1.4

1.2

27.4

36.8

mmol/l

3.53

266

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

233

1302

1.81

16.10

1.4

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1026

13103

0.75

15.95

1.6

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

117

511

2.31

15.90

2.6

3.4

65.0

57.3

2.91

340

(3052851) Hemolysis interference index of Serum or Plasma

276

1629

1.72

15.80

2.3

3.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1693

0.36

15.70

1.3

106.3

33.2

u/ml

—

102

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1179

0.23

15.59

1.2

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1135

0.23

15.36

1.0

1.1

5.8

3.6

u/ml

—

465

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

182

959

1.92

15.14

1.4

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1156

9150

1.31

14.93

2.8

2.6

1.6

1.0

e6/l

2.95

628

5093

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1143

0.24

14.84

1.2

1.4

—

(3005033) Fetal Nuchal fold Thickness US

1140

0.24

14.78

1.2

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1083

8519

1.32

14.61

3.0

2.7

4.5

2.2

e6/l

7.59

561

4482

(40761536) Microorganisms panel - Urine sediment

660

4808

1.41

14.58

4.5

3.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

893

0.16

14.53

1.3

75.5

109.1

pmol/l

—

251

(3005322) IgE [Units/volume] in Serum or Plasma

251

4115

0.60

14.44

1.2

1.3

798.1

239.3

u/ml

0.67

211

3841

(3030981) Hyaline casts [#/volume] in Urine by Automated count

404

2691

1.53

14.15

3.0

2.7

0.4

0.3

e6/l

0.71

397

2607

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1057

0.23

14.06

1.1

8.4

4.1

u/ml

—

444

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

138

2659

0.51

14.03

1.7

5.3

3.6

mg/l

1.34

113

1835

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1529

0.36

13.96

1.4

1.3

4.2

5.8

u/ml

—

163

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1553

0.37

13.86

1.3

2.5

8.9

u/ml

—

251

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

206

1165

1.79

13.73

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

124

595

2.10

13.44

1.2

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

470

3274

1.46

13.24

6.8

7.9

26.2

24.7

mmol/l

10.21

463

3255

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1248

0.32

13.14

1.4

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1774

0.43

12.94

1.1

1.2

—

(3022621) pH of Urine by Test strip

478

3361

1.45

12.83

4.3

2.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

196

2.92

12.66

4.7

6.8

26.4

24.6

mmol/l

2.54

185

(4034850)

293

1862

1.60

12.65

12.8

8.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

947

0.24

12.43

1.0

1.1

0.1

0.6

u/ml

—

215

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1572

0.41

12.33

1.1

3.6

1.5

u/ml

0.30

660

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1325

0.36

12.30

1.0

1.1

0.8

2.3

u/ml

—

339

(3022948) Iron [Moles/volume] in Serum or Plasma

1040

8314

1.29

12.30

2.1

2.6

11.3

14.0

umol/l

26.83

951

7800

(3004789) Transferrin [Mass/volume] in Serum or Plasma

966

7672

1.30

11.99

2.0

2.5

2.4

g/l

1.87

863

7192

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

839

6543

1.32

11.91

8.2

6.1

—

(44790048)

126

639

1.99

11.81

1.3

1.5

—

(44790047)

126

639

1.99

11.81

1.3

1.5

—

(44806118)

126

639

1.99

11.81

1.3

1.5

—

(44790049)

126

639

1.99

11.81

1.3

1.5

—

(40768800) Prostate Pathology biopsy report

996

0.28

11.79

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

127

2374

0.53

11.76

1.1

1.3

0.6

1.1

u/ml

0.66

210

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

674

5109

1.35

11.62

2.0

2.4

0.2

g/l

0.43

604

4804

(3003888) Timothy IgE Ab [Units/volume] in Serum

1417

0.40

11.57

1.0

1.1

3.4

6.6

u/ml

1.90

760

(3022217) INR in Platelet poor plasma by Coagulation assay

788

6118

1.32

11.54

13.0

20.0

1.2

inr

0.56

938

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

6.35

11.54

1.5

1.2

27.1

23.1

mmol/l

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

427

0.12

11.50

3.6

6.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

428

0.12

11.49

1.8

3.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

955

0.28

11.28

1.4

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

111

548

2.04

11.23

1.3

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1369

0.40

11.21

1.0

1.1

0.9

1.3

u/ml

0.30

606

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1114

0.34

11.09

1.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

115

2174

0.52

11.06

1.6

10.5

3.0

iu/ml

0.32

439

(3013707) Erythrocyte sedimentation rate by Westergren method

4634

43299

1.18

10.90

3.4

3.9

12.2

10.3

mm/h

14.49

4266

40566

(3047007) Chlamydophila sp Ab [Presence] in Serum

982

0.30

10.88

1.2

—

(3032080) INR in Blood by Coagulation assay

2393

21156

1.19

10.83

7.2

7.7

1.1

1.2

inr

5.99

882

6340

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1887

0.50

10.67

1.5

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1301

15456

0.81

10.62

3.1

3.4

21.9

21.4

0.47

445

6175

(40757373) Influenza virus identified in Isolate

100

3.51

10.56

1.6

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

981

0.31

10.55

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

394

2.17

10.18

1.7

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1840

0.50

10.12

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1074

0.36

10.02

1.1

—

14.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1219

0.40

10.02

1.3

2.1

3.9

u/ml

—

(40757494) Bilirubin.total [Moles/volume] in Blood

285

2.36

9.84

2.0

2.5

12.4

21.0

umol/l

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

130

711

1.84

9.80

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

957

0.33

9.78

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1029

0.36

9.73

1.1

4.0

3.1

u/ml

—

544

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

509

3812

1.36

9.49

2.9

2.8

121.7

156.5

ng/l

1.72

450

3389

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

552

4200

1.34

9.28

2.5

2.3

5.9

8.4

ug/l

1.64

483

3759

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

215

1380

1.57

9.01

1.2

1.4

37.7

25.4

e6/l

0.16

158

1068

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6034

58032

1.20

8.93

15.5

11.1

90.5

87.3

ml/min/173m2

21.91

4549

48143

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

214

1380

1.57

8.80

1.3

1.4

568.5

1220.5

e6/l

1.19

171

1123

(3013512) EKG study

1709

14896

1.19

8.73

4.4

3.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

343

0.15

8.49

2.2

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

129

739

1.76

8.40

1.4

1.5

—

(3015183) Erythrocyte sedimentation rate

402

0.20

8.37

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1165

0.44

8.28

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

133

772

1.74

8.28

1.6

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

127

728

1.76

8.26

1.5

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

341

2449

1.41

8.23

1.5

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

297

2.20

8.15

3.4

2.4

47.5

53.5

umol/l

0.98

255

(3012920) Ethanol [Mass/volume] in Serum or Plasma

9.10

8.08

2.1

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

240

1618

1.50

8.08

2.6

2.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1556

13535

1.19

8.05

2.2

1.9

—

(3036180) Methadone [Presence] in Urine

7.87

7.98

5.8

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

205

1340

1.54

7.98

2.1

2.5

69.4

127.9

ug/min

1.85

115

871

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

100

539

1.87

7.97

1.2

1.3

1.7

1.4

nmol/l

1.30

481

(3008116) Ketones [Moles/volume] in Urine by Test strip

127

2.84

7.77

1.6

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

511

0.19

7.76

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

133

2175

0.60

7.68

1.6

2.0

182.8

210.9

pmol/l

2.53

126

2077

(40768443) Skin Pathology biopsy report

157

2460

0.63

7.56

1.1

1.2

—

(44806420)

100

3.01

7.17

2.7

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

717

0.35

7.13

1.4

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

204

1374

1.50

6.96

1.2

1.3

4.2

3.7

mmol/l

1.83

189

1293

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

345

2563

1.36

6.85

2.2

2.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1013

0.46

6.83

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.26

6.74

1.1

1.2

10.8

16.8

u/l

0.38

(3017569) Oxygen content in Arterial blood

217

2.27

6.69

3.6

2.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

668

5443

1.25

6.65

1.7

2.2

397.0

368.7

nmol/l

2.72

601

5033

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

181

2675

0.67

6.65

1.7

2.0

37.6

39.7

u/l

0.68

158

2433

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

112

1837

0.60

6.60

1.7

2.7

195.1

184.0

0.58

101

1764

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

466

3640

1.30

6.55

3.2

4.2

90.0

93.0

ng/l

0.19

383

3230

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

102

1708

0.59

6.54

1.8

2.1

11.6

10.7

mg/l

0.60

1608

(3023419) Bacteria identified in Sputum by Culture

107

628

1.71

6.50

1.8

2.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

364

2750

1.34

6.49

9.5

11.0

25.2

24.2

mmol/l

5.18

315

2593

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

102

593

1.73

6.42

1.6

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

112

1823

0.61

6.41

1.3

1.7

0.2

g/l

0.48

107

1732

(3052592) Norovirus Ag [Presence] in Stool

3.00

6.21

1.8

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

601

0.35

6.03

1.0

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

3.08

6.03

39.5

4.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

555

6812

0.80

5.91

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

134

2053

0.65

5.91

1.6

2.3

97.5

92.9

1.28

122

1918

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

489

1.77

5.88

1.3

13.5

12.2

mmol/l

0.39

143

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

217

2.17

5.85

1.4

1.5

12.7

15.5

pmol/l

2.31

183

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

706

8435

0.82

5.81

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

480

0.29

5.74

1.2

1.0

0.5

1.2

u/ml

—

101

(40768797) Stomach Pathology biopsy report

646

7766

0.82

5.65

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

227

1633

1.40

5.55

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.24

5.52

1.2

—

mmol/l

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

219

1569

1.41

5.49

1.2

1.3

536.8

510.5

mg/l

0.26

207

1495

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

117

737

1.60

5.48

1.7

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.47

5.44

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

554

1.69

5.42

3.0

2.2

4.0

mmol/l

0.31

547

(3035285) Chloride [Moles/volume] in Venous blood

554

1.69

5.42

3.0

2.2

105.1

105.5

mmol/l

0.35

547

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

781

6610

1.20

5.38

1.5

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

141

934

1.52

5.31

1.5

1.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

968

8394

1.18

5.06

2.2

2.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.89

4.98

1.4

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

167

2365

0.70

4.97

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

384

4811

0.79

4.92

1.9

2.6

10.3

10.6

g/l

0.48

347

4414

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

540

6513

0.82

4.89

5.0

4.0

29.6

31.0

2.57

389

4668

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1084

0.57

4.79

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

689

0.46

4.77

1.2

1.5

—

25.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1082

12256

0.86

4.72

1.4

1.5

2.1

2.4

g/l

7.21

584

7987

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

177

2.15

4.70

1.2

—

(4024509)

425

1.72

4.68

1.9

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

175

1243

1.42

4.67

1.3

2.4

1.0

0.8

nmol/l

1.63

138

1054

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

830

7158

1.18

4.63

2.1

2.6

18.2

24.1

29.26

647

6231

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1047

0.57

4.62

1.1

121.6

115.4

0.93

969

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

483

0.37

4.60

1.2

1.1

—

27.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

481

0.37

4.57

1.3

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1779

19461

0.89

4.56

3.0

3.9

1.9

2.1

ug/l

0.34

1588

17793

(3020874) Milk IgE Ab [Units/volume] in Serum

466

0.36

4.56

1.1

1.0

0.4

1.9

u/ml

—

119

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

480

0.37

4.55

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

480

0.37

4.55

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1104

0.59

4.53

1.3

1.7

0.5

0.8

g/l

1.90

840

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

822

0.52

4.53

2.3

2.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

224

1667

1.35

4.53

1.5

1.8

—

(3000012) Reticulocyte production index

248

1.94

4.52

1.4

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

477

0.38

4.49

1.3

1.2

—

(3042733) HLA Ab [Presence] in Serum

282

0.28

4.48

6.3

5.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

476

0.38

4.47

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

476

0.38

4.47

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

124

1812

0.68

4.42

2.0

2.8

3.9

3.6

g/l

1.75

117

1724

(3027135) IgG subclass 1 [Mass/volume] in Serum

682

0.48

4.41

1.1

1.4

6.3

6.7

g/l

0.52

460

(3024139) IgG subclass 3 [Mass/volume] in Serum

681

0.48

4.40

1.1

1.4

0.4

g/l

0.07

461

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

366

0.30

4.36

1.3

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

538

1.61

4.24

3.1

2.2

—

(4062490)

684

0.49

4.22

1.1

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

271

0.29

4.22

1.8

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

199

2.02

4.21

2.7

4.0

—

(3045142) Bone marrow Pathology biopsy report

588

0.46

4.20

1.2

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

681

0.50

4.17

1.1

1.4

2.4

3.0

g/l

1.56

464

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

284

1.84

4.17

1.6

—

(3021788) Differential panel - Synovial fluid

1027

0.59

4.15

1.5

—

(4306422)

1089

0.60

4.14

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

138

963

1.44

4.10

1.4

21.1

24.8

u/l

0.75

110

789

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

782

0.53

4.10

1.1

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

536

1.59

4.07

2.7

3.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

324

1.77

4.03

1.0

32.7

45.4

ng/l

3.29

231

(3014271) Vancomycin [Susceptibility]

182

2.04

4.03

2.6

2.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1481

0.66

4.02

1.3

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1437

13020

1.13

4.01

1.8

1.1

1.0

mg/l

0.22

1068

9725

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

326

1.75

3.95

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

157

1130

1.40

3.95

4.5

3.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

225

0.27

3.89

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

285

1.79

3.83

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

322

1.74

3.82

1.0

229.0

327.1

ng/l

4.46

235

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

322

1.74

3.82

1.0

737.4

756.7

ng/l

0.13

227

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

691

0.53

3.69

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

210

1.91

3.66

3.9

2.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

200

0.25

3.66

2.8

3.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1332

0.66

3.66

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1308

0.66

3.65

1.6

1.7

7716.1

15342.5

e6/l

2.49

950

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

106

1532

0.69

3.64

1.1

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

219

0.27

3.59

1.3

1.9

241.3

165.8

—

208

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

469

0.45

3.55

1.0

1.3

0.0

0.8

u/ml

—

191

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

781

0.57

3.50

1.1

92.0

98.0

0.75

748

(3044290) Cell count panel - Cerebral spinal fluid

175

1311

1.34

3.48

1.2

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.89

3.46

2.3

2.2

—

(3000330) Specific gravity of Urine by Test strip

299

2408

1.25

3.44

3.9

3.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1049

0.64

3.43

1.1

1.2

—

(3036489) Thrombin time

176

2318

0.75

3.42

1.7

2.2

19.8

21.3

6.29

150

2004

(3024471) HLA-A [Type]

260

0.35

3.40

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

445

0.45

3.37

1.3

1.2

—

46.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

7.00

3.36

2.9

2.0

4.2

4.7

mmol/l

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

101

1449

0.69

3.36

1.2

1.3

233.6

256.9

u/ml

0.50

945

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1180

10675

1.13

3.35

1.8

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.72

3.31

2.2

2.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

372

0.40

3.31

1.1

10.6

10.3

iu/ml

—

103

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

407

3400

1.21

3.31

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

3.30

0.0

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

155

2.00

3.28

2.1

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

158

1177

1.35

3.28

5.3

3.1

24.3

26.0

mg/l

0.30

118

712

(3024932) HLA-DR beta [Type]

256

0.35

3.27

1.1

—

(3022313) Gas panel - Capillary blood

283

2282

1.25

3.24

3.8

3.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

306

3732

0.81

3.17

1.5

1.9

1.3

g/l

0.03

277

3450

(40765089) Chromosome analysis panel - Blood by G-banded

319

0.38

3.12

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.80

3.08

2.7

2.3

0.8

0.5

u/field

0.34

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

107

756

1.42

3.07

6.3

6.9

11.2

10.9

mg/l

0.25

700

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1092

0.67

3.06

1.2

1.3

3.8

4.2

u/ml

0.06

359

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

212

0.33

3.04

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

113

811

1.40

2.98

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

1850

0.75

2.96

2.4

2.3

7.6

7.3

g/l

1.14

1426

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

1849

0.75

2.95

2.4

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

1849

0.75

2.95

2.4

2.2

3.6

3.8

g/l

0.74

1356

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

198

2510

0.78

2.92

3.0

3.3

57.2

47.2

u/ml

0.23

185

2426

(21494434) Karyotype in Bone marrow

444

0.49

2.88

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

166

1274

1.31

2.86

2.0

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

1714

0.74

2.85

2.5

2.3

10.2

10.3

g/l

0.07

1484

(3049717) Cytology report of Urine Cyto stain

131

1748

0.74

2.85

2.1

2.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

415

0.48

2.84

1.0

—

(3034426) Prothrombin time (PT)

275

0.36

2.83

1.2

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

346

0.43

2.83

1.5

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

237

1908

1.25

2.80

2.1

1.8

—

(3006270) Folate [Moles/volume] in Blood

452

0.51

2.79

1.1

330.4

389.8

nmol/l

0.90

414

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1019

9243

1.12

2.77

2.3

2.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

130

1724

0.75

2.73

2.7

3.1

1.6

1.4

mg/l

1.26

120

1620

(3048689) Calprotectin [Mass/mass] in Stool

723

8105

0.88

2.71

1.9

2.6

135.8

133.0

ug/g

0.09

549

6582

(3010503) CD19 cells [#/volume] in Blood

394

0.48

2.71

2.5

2.7

0.2

0.3

e9/l

0.94

385

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

186

2351

0.79

2.71

1.6

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1073

0.69

2.68

1.2

1.3

2.4

4.3

u/ml

3.53

485

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

216

0.37

2.65

1.0

—

(3042631) Mycobacterium sp identified in Specimen

631

1.42

2.57

2.3

2.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

308

1.59

2.51

1.3

1.4

6.4

5.7

mmol/l

2.35

292

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

158

1229

1.29

2.51

1.3

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

326

3852

0.84

2.49

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

271

0.41

2.47

2.0

1.4

3.4

ug/l

2.70

238

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

121

1594

0.76

2.46

2.6

2.3

0.4

0.8

g/l

1.52

1409

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

135

1751

0.77

2.45

2.4

2.3

3.2

3.1

g/l

1.05

1398

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

365

0.49

2.44

5.9

7.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

648

5768

1.14

2.43

1.6

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

429

0.53

2.41

2.7

1.9

2.7

4.0

mg/l

3.44

413

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

363

0.49

2.40

2.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

253

0.39

2.40

1.0

1.1

—

(4010399)

464

4046

1.16

2.36

1.5

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

259

2149

1.21

2.36

1.5

1.8

1.9

1.5

g/l

6.30

218

1872

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

550

1.42

2.35

1.5

2.0

22.2

24.9

ug/l

0.22

541

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

915

0.69

2.35

1.1

1.6

1.5

g/l

0.81

834

(3006653) Thiamine [Moles/volume] in Blood

299

1.58

2.32

1.1

1.3

150.4

135.5

nmol/l

1.24

299

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.22

2.27

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

669

0.64

2.26

2.0

2.1

4.2

6.7

umol/l

1.82

477

(3044927) Protein electrophoresis panel - Urine

445

0.56

2.25

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1703

16001

1.08

2.22

4.2

2.9

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

5.56

2.21

1.2

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

677

0.65

2.21

1.4

1.6

58.9

56.7

0.15

430

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

389

0.54

2.18

2.3

3.1

101.3

109.1

nmol/l

0.13

384

(3003327) Ova and parasites identified in Stool by Light microscopy

179

2209

0.81

2.18

1.4

1.7

—

(40768446) Kidney Pathology biopsy report

296

0.47

2.17

1.6

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

426

0.56

2.16

1.3

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

322

0.50

2.16

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

424

0.56

2.13

1.2

1.1

ratio

—

150

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

111

1441

0.77

2.08

2.7

2.1

37.1

38.1

g/l

1.05

1279

(4268621)

750

0.68

2.07

2.1

2.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

879

0.70

2.07

2.2

3.4

31.0

530.3

u/ml

0.86

834

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

103

1.94

2.04

4.0

2.0

5.8

7.8

mmol/l

—

(3014051) Protein [Presence] in Urine by Test strip

146

1159

1.26

2.04

2.8

2.1

—

(3029075) Extractable nuclear Ab panel - Serum

176

0.40

2.02

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

111

1434

0.77

2.01

1.3

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

159

0.38

2.01

1.0

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

250

2104

1.19

2.01

2.3

2.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.63

2.00

1.4

1.7

35.6

46.0

umol/l

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

145

0.34

2.00

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

145

0.34

2.00

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

145

0.34

2.00

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

217

1804

1.21

1.99

3.0

3.3

0.2

0.3

g/l

3.30

829

(3007461) Platelets [#/volume] in Blood

7071

70140

1.14

1.95

48.9

17.2

252.1

252.3

e9/l

0.09

6969

68577

(4133840)

229

0.44

1.94

1.6

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

399

0.58

1.93

1.0

1.1

1.2

1.1

u/l

—

189

(40768793) Breast Pathology biopsy report

1051

0.74

1.93

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

295

0.51

1.92

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

546

0.64

1.92

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

461

4085

1.14

1.91

1.2

80.0

153.7

iu/ml

4.83

154

1542

(3033799) Differential panel - Peritoneal fluid

172

0.41

1.90

1.4

2.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

112

1431

0.78

1.88

2.6

2.1

0.0

g/l

0.08

1338

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

340

1.47

1.88

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

121

1.82

1.87

2.2

3.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

395

0.58

1.87

1.3

1.6

8.7

7.9

mmol/l

0.44

253

(4281824)

518

0.64

1.87

1.1

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

103

1328

0.77

1.87

1.4

1.5

110.9

110.2

u/ml

0.03

280

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

114

1.84

1.86

1.4

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

421

4758

0.88

1.86

3.4

2.4

71.8

71.1

ml/min/173m2

0.11

166

1750

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

238

0.46

1.86

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

941

0.73

1.85

1.3

1.5

0.2

0.3

nmol/l

2.75

749

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

475

1.39

1.84

1.2

1.3

2.0

mmol/l

0.16

443

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.98

1.84

1.1

1.2

2.2

1.8

mmol/l

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1054

0.75

1.84

1.6

2.8

500.0

1088.7

u/ml

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

222

1.58

1.81

2.4

2.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

377

1.44

1.79

2.0

1.9

3.4

1.8

u/field

1.10

172

(3003434) Protein [Mass/volume] in Pleural fluid

556

1.35

1.76

1.3

1.5

36.1

34.2

g/l

0.82

501

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

102

1305

0.78

1.76

2.8

2.2

0.0

g/l

0.00

1227

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

151

0.40

1.76

1.0

1.2

—

(3011412) CD3 cells [#/volume] in Blood

629

0.68

1.75

2.1

2.5

1.3

1.2

e9/l

0.32

372

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

348

0.57

1.73

1.1

1616.4

1460.3

miu/ml

0.26

348

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

281

1.50

1.73

1.9

1.6

2.1

3.7

u/field

0.68

213

(3037692) Legionella sp identified in Specimen by Organism specific culture

192

0.47

1.72

1.1

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

283

0.53

1.71

1.0

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

104

1319

0.79

1.68

2.8

2.2

0.0

g/l

0.50

1229

(3044941) Cell count panel - Synovial fluid

867

0.74

1.68

1.4

—

(3022689) Creatine [Moles/volume] in Urine

195

1.59

1.68

1.4

1.5

—

(40761511) CBC panel - Blood by Automated count

6566

64956

1.09

1.63

23.0

11.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

419

1.39

1.62

1.1

1.4

6.2

6.3

mmol/l

0.09

388

(3035941) MCH [Entitic mass]

7071

70207

1.12

1.61

48.5

17.1

30.0

30.3

41.62

7004

69419

(3024731) MCV [Entitic volume]

7071

70211

1.12

1.59

48.6

17.1

90.1

90.4

8.23

7004

69423

(3011648) Oxygen content in Venous blood

481

1.35

1.58

1.4

2.5

12.3

11.3

1.14

481

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

436

0.64

1.57

2.1

2.7

0.2

e9/l

0.40

373

(3023323) Follitropin [Units/volume] in Serum or Plasma

265

3049

0.86

1.56

1.4

22.8

27.2

iu/l

1.70

208

2620

(3027923) C peptide [Moles/volume] in Serum or Plasma

313

1.44

1.56

1.3

1.5

1.1

1.2

nmol/l

0.12

241

(3018677) aPTT in Platelet poor plasma by Coagulation assay

891

8278

1.09

1.55

1.8

2.3

30.2

29.7

1.42

855

8054

(3026361) Erythrocytes [#/volume] in Blood

7071

70225

1.12

1.52

48.8

17.2

4.6

e12/l

0.75

6960

68507

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

480

0.67

1.52

2.2

2.7

760.6

741.4

e6/l

—

194

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

551

0.69

1.52

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

283

0.56

1.50

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.00

1.49

0.0

1.0

—

0.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

478

0.67

1.49

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

644

1.29

1.48

1.2

1.5

—

(3044007) Cell count panel - Peritoneal fluid

168

0.48

1.46

1.3

2.1

—

(3004775) Volume in Urine collected for unspecified duration

445

1.35

1.46

2.2

2.4

835.5

644.9

1.83

322

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

569

0.70

1.45

1.1

245.2

267.4

mg/l

0.50

500

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

507

1.32

1.43

2.3

2.8

—

(3010813) Leukocytes [#/volume] in Blood

7071

70245

1.12

1.43

49.6

17.2

7.3

6.6

e9/l

127.22

6956

68532

(3036603) Volume of Urine

377

0.64

1.43

1.3

1.6

2062.4

2142.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

516

1.32

1.43

1.3

1.5

7195.8

2589.1

e6/l

0.63

373

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

151

0.46

1.43

2.0

1.9

22.7

28.5

u/l

—

141

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

449

0.67

1.43

2.0

2.7

540.8

526.1

e6/l

0.06

375

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

474

1.33

1.41

1.3

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

474

1.33

1.41

1.3

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

474

1.33

1.41

1.3

1.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

387

0.64

1.40

1.1

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

137

0.44

1.39

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

7071

70253

1.11

1.39

49.1

17.2

137.4

139.2

g/l

19.88

7005

69456

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

225

0.53

1.39

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

587

0.71

1.39

1.1

1.2

47.9

40.9

mg/l

0.82

493

(40768441) Liver Pathology biopsy report

458

0.68

1.39

1.1

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

296

1.42

1.39

1.3

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

325

0.61

1.38

1.1

101.1

97.9

0.24

266

(3007566) Smooth muscle Ab [Titer] in Serum

219

1894

1.16

1.37

1.2

1.3

80.7

143.4

titre

1.00

177

(3045424) Erythrocytes [Presence] in Urine

112

912

1.23

1.36

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

2.94

1.36

1.8

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.94

1.36

1.4

1.2

2.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

698

0.74

1.34

1.3

1.5

—

(3035880) pH of Pleural fluid

240

1.46

1.34

1.0

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.33

0.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

1.33

0.0

2.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

1.32

0.0

2.8

—

0.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

0.00

1.32

0.0

2.7

—

85.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

696

0.75

1.32

1.3

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

144

1.60

1.31

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

149

0.47

1.31

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.09

1.30

1.6

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

456

1.32

1.27

1.4

25807.9

69296.1

e6/l

1.44

268

(3016228) CD19 cells/100 cells in Blood

268

0.60

1.27

2.3

2.0

9.1

8.8

0.05

260

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

285

1.41

1.27

1.2

1.3

14.1

13.1

u/l

0.26

266

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

303

1.39

1.24

1.3

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

117

0.43

1.24

1.0

2.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

399

0.68

1.24

1.3

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

266

0.60

1.24

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.63

1.21

1.0

—

(3045788) Cell count panel - Pleural fluid

417

1.32

1.20

1.3

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

445

4870

0.91

1.20

2.9

4.3

27.8

31.0

ug/l

0.06

374

3890

(3020491) Glucose [Moles/volume] in Blood

435

1.31

1.19

2.3

1.6

7.5

6.6

mmol/l

1.05

298

(3045414) Leukocytes [Presence] in Urine

272

2416

1.13

1.19

2.2

1.8

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

197

1.47

1.18

1.4

1.7

—

604.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

198

1725

1.15

1.16

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

199

1735

1.15

1.16

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

381

0.68

1.16

9.3

7.0

59.8

7178.4

u/ml

—

100

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

211

0.57

1.16

1.2

2.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

129

0.46

1.15

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

325

1.36

1.15

1.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

1.15

0.0

1.1

—

1.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

1.15

0.0

1.1

—

8.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

260

0.61

1.15

2.2

2.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

623

5787

1.08

1.14

2.6

4.7

228.4

238.5

u/l

1.07

569

5516

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

134

1.57

1.14

1.3

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

1.14

0.0

1.1

—

(3024316) Viscosity of Plasma

0.00

1.14

0.0

1.4

—

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

430

1.30

1.14

1.4

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

125

1053

1.19

1.12

1.0

1.1

39.6

582.5

iu/ml

0.57

253

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

267

1.39

1.12

1.3

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.00

1.12

1.0

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.67

1.10

1.8

1.7

112.9

137.0

ng/l

0.43

(42529406) Shigella sp [Presence] in Stool by Culture

199

1745

1.14

1.09

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.95

1.08

1.0

1.6

—

(40765096) Chromosome analysis panel by Banding

166

0.54

1.07

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

267

0.64

1.07

1.1

173.6

244.9

ng/l

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

693

0.78

1.06

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

691

0.78

1.04

1.3

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

407

0.71

1.04

4.0

2.4

—

(36660697) Celiac disease serology panel - Serum

527

4887

1.08

1.03

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

149

0.54

1.03

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.92

1.02

1.2

4.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

688

0.78

1.02

1.3

1.5

—

(3014891) Appearance of Pleural fluid

1.89

1.01

1.4

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

108

0.46

1.00

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

742

0.79

1.00

1.1

—

16.9

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

0.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

224

0.62

0.97

1.3

2.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.97

0.0

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.97

0.0

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.97

0.0

1.1

—

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

302

3323

0.90

0.96

1.3

1.4

—

(3028433) Virus identified in Specimen by Culture

211

0.62

0.96

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

223

0.63

0.96

1.2

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

223

0.63

0.96

1.2

2.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

488

1.25

0.94

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

511

0.76

0.93

1.3

1.4

140404.0

96926.6

e6/l

0.14

351

(3036048) Francisella tularensis Ab [Titer] in Serum

172

0.58

0.93

1.0

1.2

—

216.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.72

0.92

1.5

1.9

0.8

1.1

mmol/l

—

(3016018) Differential panel - Cerebral spinal fluid

689

1.21

0.92

1.1

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.91

1.1

—

(3024263) Appearance of Synovial fluid

303

0.69

0.91

1.8

1.9

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

102

0.49

0.89

4.0

6.3

48.8

45.5

ug/min

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

529

0.77

0.88

1.4

1.5

28.2

32.0

0.28

325

(3020393) Adenovirus Ag [Presence] in Stool

1.91

0.88

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.65

0.87

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.65

0.87

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

293

3210

0.91

0.87

2.1

2.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

358

0.73

0.87

1.3

—

(3047189) Immunofixation for 24 hour Urine

229

0.65

0.87

1.3

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

307

1.30

0.86

1.1

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

136

1.47

0.86

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

104

888

1.17

0.86

1.2

1.3

19.2

38.9

u/l

2.04

776

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

192

0.62

0.85

1.1

1.2

108.0

101.5

0.28

177

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

216

0.65

0.85

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

523

1.23

0.84

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

139

0.58

0.83

1.1

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

444

0.76

0.82

1.1

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

1546

14942

1.04

0.80

3.8

4.0

92.7

92.4

0.15

1484

14595

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

497

0.78

2.0

2.1

11.1

15.0

1.36

232

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

163

0.61

0.78

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.62

0.78

1.2

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.77

0.0

1.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.1

—

0.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.77

0.0

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

372

0.75

0.77

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

126

0.56

0.77

1.7

1.3

120.3

105.5

—

121

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

439

0.77

0.76

1.1

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.64

0.75

1.2

1.3

0.6

1.4

mmol/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

358

0.75

0.74

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

134

0.60

0.73

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

134

0.60

0.73

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

134

0.60

0.73

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

134

0.60

0.73

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

254

0.71

0.73

2.2

2.7

—

(3003338) MCHC [Mass/volume]

5506

55588

0.96

0.72

47.3

14.5

332.0

334.0

g/l

47.66

5476

55211

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

107

0.56

0.72

1.3

2.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

666

0.82

0.72

1.3

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.75

0.71

2.4

1.4

—

(44813793)

433

0.78

0.70

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

707

0.83

0.70

1.3

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2563

25081

1.03

0.69

2.7

2.8

110.7

127.0

ug/l

1.48

2368

23595

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

102

1.47

0.67

1.1

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

156

0.64

0.67

1.0

1.1

4.8

7.2

mg/g

—

150

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

203

0.69

0.66

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

203

0.69

0.66

2.4

2.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

616

0.83

0.66

1.2

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

188

1.33

0.66

1.0

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

163

1804

0.90

0.65

1.1

9.5

5.2

u/ml

—

270

(3028717) Thiamine [Mass/volume] in Blood

1.57

0.65

1.1

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

199

1.31

0.62

23.1

1.3

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

5.3

—

3.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.60

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.59

0.0

1.2

—

(40758358) Immune stain study

0.00

0.59

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.59

0.0

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

768

0.86

0.59

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

197

0.71

0.58

1.1

106.2

89.0

—

101

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.58

0.0

1.2

—

0.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

162

0.68

0.58

1.5

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

265

0.75

0.58

2.4

1.6

28.9

29.1

umol/l

0.04

251

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

253

0.75

0.57

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

241

0.75

0.56

1.2

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

241

0.75

0.56

1.2

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

149

0.67

0.56

12.4

6.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

150

1650

0.91

0.56

2.4

3.5

0.3

u/ml

0.03

928

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

709

1.14

0.55

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

152

1383

1.10

0.55

1.4

1.9

2.4

4.6

iu/l

5.39

524

(4027681)

450

0.82

0.55

1.3

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

666

0.85

0.55

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

147

0.68

0.53

1.0

1.2

36.3

38.1

g/l

—

(3016244) Insulin [Units/volume] in Serum or Plasma

393

0.81

0.52

2.4

3.4

30.9

27.8

mu/l

0.16

376

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

100

1.40

0.51

1.0

1.2

57.3

56.5

ng/l

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1054

0.89

0.51

2.7

3.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

471

1.17

0.51

3.3

3.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

467

0.83

0.50

2.6

2.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.47

0.50

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

382

3621

1.06

0.49

1.8

2.0

—

(3016750) Collection duration of Urine

344

1.19

0.48

1.8

2.3

514.3

492.9

min

0.53

266

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

126

1384

0.91

0.48

2.8

3.5

43.6

55.4

mg/l

0.43

1115

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

624

1.14

0.48

1.2

1.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

255

0.78

0.46

1.4

1.3

—

77.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1035

0.90

0.46

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

232

0.78

0.45

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

232

0.78

0.45

1.3

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

117

0.68

0.45

1.1

—

2.4

—

(3018133) Calcium [Moles/volume] in Urine

0.61

0.45

1.4

1.9

2.3

2.8

mmol/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

237

1.22

0.45

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

164

0.73

0.45

1.1

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

112

1.34

0.44

2.1

3.0

31.6

51.4

mg/l

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

264

0.79

0.44

2.5

1.6

2.1

2.0

umol/l

0.36

248

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.64

0.42

1.0

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.52

0.41

1.0

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.41

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.41

0.0

1.1

—

82.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

281

2966

0.95

0.40

1.1

400.0

191.1

titre

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

7.2

—

0.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

172

0.76

0.40

1.5

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

412

0.85

0.40

3.1

2.7

38.1

40.3

0.19

133

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.47

0.40

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

138

0.72

0.40

11.1

6.8

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.40

0.0

6.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

454

0.86

0.39

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

484

1.14

0.39

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.38

0.38

8.0

6.6

—

(3037756) Immunofixation for Serum or Plasma

100

914

1.10

0.38

1.2

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

483

0.87

0.37

2.0

2.1

—

(3012441) Differential panel - Pleural fluid

439

1.14

0.37

1.4

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

114

0.70

0.37

6.6

7.1

—

(40768806) Pleura Pathology biopsy report

449

1.14

0.37

1.4

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

487

1.13

0.36

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

289

0.83

0.36

1.2

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

289

0.83

0.36

1.2

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

289

0.83

0.36

1.2

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

289

0.83

0.36

1.2

2.1

—

(3025130) Human papilloma virus identified in Specimen

734

0.90

0.36

1.6

1.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.64

0.35

1.2

1.5

—

(3002619) Bacteria identified in Specimen by Culture

108

1.30

0.35

1.3

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

122

0.74

0.35

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

861

1.09

0.35

1.3

8.7

7.1

mmol/l

2.78

651

(3019225) pH of Specimen

473

4903

0.96

0.34

3.9

4.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

178

0.79

0.34

1.0

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

216

2281

0.95

0.34

1.3

1.5

7.9

8.5

u/l

0.32

168

1871

(3025941) Bacteria identified in Stool by Culture

354

3691

0.96

0.34

1.3

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1054

0.92

0.34

1.3

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.70

0.33

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

231

0.82

0.32

1.2

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

385

3998

0.96

0.31

2.1

2.6

65.1

66.9

g/l

4.41

342

3713

(3034860) Kappa light chains.free [Mass/volume] in Serum

129

1380

0.93

0.31

2.8

3.5

53.6

53.7

mg/l

0.00

100

1109

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

210

1994

1.05

0.31

3.9

3.4

25.3

24.8

mmol/l

1.73

205

1850

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

618

1.10

0.31

1.3

—

29.2

—

(3032057) Clostridioides difficile [Presence] in Stool

0.72

0.30

1.7

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

176

1860

0.94

0.30

1.4

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

259

1.16

0.29

1.1

83.4

88.2

u/l

0.13

207

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

287

2752

1.04

0.29

2.0

1.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

250

1.16

0.29

1.7

2.1

159.9

215.0

ug/min

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

249

0.84

0.29

1.0

1.2

—

(3051651) Icteric interference index of Serum or Plasma

345

1.13

0.28

2.4

3.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

169

1781

0.95

0.27

2.4

3.9

1839.0

2971.9

u/ml

0.25

146

1543

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

126

1338

0.94

0.26

2.8

3.4

1.3

2.8

ratio

0.92

116

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

426

0.89

0.26

3.6

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.25

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

213

0.84

0.25

1.7

1.8

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

828

0.93

0.24

1.3

0.2

nmol/l

0.69

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

161

1.18

0.24

1.1

—

(4212803)

1.25

0.22

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

389

0.90

0.22

1.5

1.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

257

1.13

0.22

1.1

22.5

21.9

u/l

0.02

198

(3011985) Renin [Units/volume] in Plasma

768

1.07

0.21

1.2

1.6

49.4

61.3

mu/l

0.26

702

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

163

1.17

0.21

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.3

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.2

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

6.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.21

0.0

1.1

—

18.1

—

(3025315) Body weight

1.16

0.21

6.8

3.6

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.16

0.21

1.2

1.1

—

6.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

822

0.94

0.21

1.3

0.8

2.0

nmol/l

0.41

792

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

522

0.92

0.20

1.3

1.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.20

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.20

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.20

0.0

2.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.20

0.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.20

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.20

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

164

1.16

0.20

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.25

0.20

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

302

0.89

0.19

1.7

1.5

46.4

21.8

u/ml

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

569

1.07

0.18

1.2

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

1040

0.95

0.17

2.4

3.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

620

1.07

0.17

1.3

1.1

—

(3000285) Sodium [Moles/volume] in Blood

0.76

0.17

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

719

1.06

0.16

1.3

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

158

1.14

0.16

1.1

1.4

111.6

135.1

nmol/l

0.30

119

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.20

0.16

3.3

2.2

—

(3051611) Lipemic interference index of Serum or Plasma

536

1.06

0.15

2.3

3.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.10

0.15

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.82

0.13

1.3

1.9

34.4

44.2

pmol/l

—

(3012565) Volume of 24 hour Urine

305

0.92

0.13

1.4

2.4

2515.9

2107.5

0.40

282

(44806071)

106

0.85

0.13

1.3

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

324

0.93

0.12

1.0

1.2

13.5

21.1

u/l

1.04

277

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

172

1.10

0.11

1.1

—

(3004451) EKG impression Narrative

250

1.08

0.11

1.2

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

943

0.96

0.10

1.2

1.4

—

(3006462) Nitrate [Presence] in Urine

229

0.92

0.10

2.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

829

1.04

0.10

1.5

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

739

0.96

0.10

1.3

—

(4146454)

527

1.04

0.09

2.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

665

1.04

0.09

3.2

3.0

0.8

nmol/l

0.24

500

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.05

0.08

1.8

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.03

0.08

1.2

1.1

—

(4015189)

123

0.89

0.08

2.9

2.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.83

0.07

1.2

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

174

0.92

0.07

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1380

13727

1.01

0.07

1.3

2.4

1.8

u/ml

0.57

375

3880

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.03

0.07

13.0

9.6

3.9

6.2

mmol/l

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.87

0.07

1.0

2.0

—

(3000060) B lymphocytes [#/volume] in Blood

183

0.93

0.06

1.8

2.2

177.5

155.7

e6/l

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

721

1.03

0.06

1.3

1.4

324.7

325.1

pmol/l

0.00

557

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

334

0.96

0.05

1.3

1.6

10.0

5.4

u/l

0.42

168

(4211845)

252

0.95

0.05

2.7

2.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

566

1.02

0.04

1.9

2.1

23.0

23.6

mg/l

0.03

163

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

228

2302

0.99

0.04

1.3

134.9

215.4

miu/ml

2.04

1067

(3024891) Influenza virus A+B Ag [Presence] in Specimen

179

1810

0.99

0.04

1.3

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

230

0.96

0.03

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

558

1.02

0.03

1.1

2.0

18.0

19.2

nmol/l

0.57

525

(3000570) Elastase.pancreatic [Mass/mass] in Stool

159

1602

0.99

0.02

1.3

1.4

298.5

280.8

ug/g

0.48

907

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

173

1.04

0.01

1.3

1.5

13.1

8.6

ug/l

1.41

173

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

557

0.99

0.01

1.0

1.2

53.7

60.0

u/l

0.51

385

(3001556) Androgen free Index in Serum or Plasma

1.06

0.01

2.3

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

134

1.04

0.00

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

384

1.02

0.00

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

187

1.02

0.00

6.6

10.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

106

1.04

0.00

1.0

1.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

186

1.02

0.00

1.2

2.1

86.2

63.1

ug/l

0.45

181

(3017704) Immunofixation for Urine

256

1.02

0.00

1.1

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

108

1084

1.00

0.00

1.3

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

515

1.01

0.00

1.1

1.5

13.4

12.2

umol/l

0.36

492

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

555

1.01

0.00

1.1

290.0

282.3

mg/l

0.33

508

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

454

4545

1.00

0.00

2.0

2.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.02

0.00

1.4

40.8

23.1

—

(3034770) Mitochondria Ab [Titer] in Serum

186

1862

1.00

0.00

1.1

1.3

544.0

961.5

titre

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

261

1.00

0.00

1.0

7.3

63.6

1750.8

mg/l

0.80

183

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

3.3

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.3

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.9

—

10.4

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

11.0

—

(3019174) dRVVT (LA screen)

0.94

0.00

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

2.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.85

0.00

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.00

0.00

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.1

—

(3021374) Sirolimus [Mass/volume] in Blood

0.00

0.0

7.5

—

6.8

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.91

0.00

1.2

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.3

—

7.5

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.2

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.3

—

2.5

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

7.8

—

1.6

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.3

—

33.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.98

0.00

1.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.3

—

70.8

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SCHZPHR and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_SCHZPHR	2.538 [2.31, 2.79]	< 0.001
Birth year	1.0 [0.99, 1.01]	0.945

During the follow-up period (1.1.1998 — 31.12.2019), 2673 out of 12837 females with F5_SCHZPHR died.

Males

Parameter	HR [95% CI]	p-value
F5_SCHZPHR	3.467 [3.15, 3.81]	< 0.001
Birth year	0.982 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2921 out of 15734 males with F5_SCHZPHR died.

Mortality risk

Mortality risk for people of age

years, who have F5_SCHZPHR.

N-year risk	Females	Males
1	0.237%	0.543%
5	1.347%	3.481%
10	3.932%	8.162%
15	7.645%	15.011%
20	13.697%	24.556%

Relationships between endpoints

↥

Index endpoint: F5_SCHZPHR – Schizophrenia

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Schizophrenia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints